Schedule 13G: Capital Research Discloses 5.3% Position in Albemarle (ALB)

Rhea-AI Filing Summary

Capital Research Global Investors filed a Schedule 13G reporting beneficial ownership of 6,307,813 shares of Albemarle Corporation common stock, representing 5.3% of the 119,818,504 shares believed outstanding as of the reporting event date. The filing notes that reported holdings include 4,721,204 Convertible Preferred Stocks, which the filer states represent 2,157,590 common shares.

The submission identifies CRGI as an investment management division and includes a certification that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. The filing is signed by Jae Won Chung on 08/05/2025 and lists issuer and filer addresses.

Positive

• Disclosure of material stake: Reports beneficial ownership of 6,307,813 shares (5.3%), a material disclosure for investors.
• Transparency on convertible instruments: States that 4,721,204 Convertible Preferred Stocks represent 2,157,590 common shares included in the total.
• Certification of passive intent: Filers certify holdings are held in the ordinary course and not for control purposes.

Negative

• None.

Insights

Financial Analyst

TL;DR: Capital Research reports a passive 5.3% stake (6.31M shares) in Albemarle on Schedule 13G.

Capital Research Global Investors discloses ownership of 6,307,813 shares, equal to 5.3% of Albemarle's ~119.8M shares outstanding. The filing explicitly counts 4,721,204 Convertible Preferred Stocks as representing 2,157,590 common shares in its total. This is a standard passive disclosure under a Schedule 13G format and includes the filer's certification that the stake is held in the ordinary course of business and not to influence control. For market impact, the position is material in size but presented as non-control.

Corporate Governance Expert

TL;DR: Filing confirms passive ownership and an explicit certification that holdings are not intended to change control.

The Schedule 13G includes a formal certification stating the securities "were acquired and are held in the ordinary course of business" and "were not acquired and are not held for the purpose of or with the effect of changing or influencing the control" of Albemarle. The document is signed by a Capital Research officer on 08/05/2025. The disclosure aids transparency for board and governance monitoring but contains no indication of active governance intent.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Albemarle Corp.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

012653101

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 012653101

1

Names of Reporting Persons

Capital Research Global Investors

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 6,307,813.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 6,307,813.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

6,307,813.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.3 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Albemarle Corp.
(b)	Address of issuer's principal executive offices: 4250 Congress Street, Suite 900, Charlotte, NC 28209, United States of America
Item 2.
(a)	Name of person filing: Capital Research Global Investors
(b)	Address or principal business office or, if none, residence: 333 South Hope Street, 55th Fl, Los Angeles, CA 90071
(c)	Citizenship: N/A
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 012653101
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 6,307,813 ** **Capital Research Global Investors ("CRGI") is a division of Capital Research and Management Company ("CRMC"), as well as its investment management subsidiaries and affiliates Capital Bank and Trust Company, Capital International, Inc., Capital International Limited, Capital International Sarl, Capital International K.K., Capital Group Private Client Services, Inc., and Capital Group Investment Management Private Limited (together with CRMC, the "investment management entities"). CRGI's divisions of each of the investment management entities collectively provide investment management services under the name "Capital Research Global Investors." CRGI is deemed to be the beneficial owner of 6,307,813 shares or 5.3% of the 119,818,504 shares believed to be outstanding. Shares reported include 4,721,204 Convertible Preferred Stocks, which represent 2,157,590 Common Stock.
(b)	Percent of class: 5.3 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 6,307,813
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 6,307,813
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Capital Research Global Investors

Signature:	Jae Won Chung
Name/Title:	Vice President and Senior Counsel II, Capital Research and Management Company
Date:	08/05/2025

FAQ

Who filed the Schedule 13G for Albemarle (ALB)?

The filing was made by Capital Research Global Investors, a division of Capital Research and Management Company.

How many Albemarle (ALB) shares does Capital Research report owning?

The filer reports beneficial ownership of 6,307,813 shares, representing 5.3% of shares outstanding.

Does the filing indicate the stake is for control of Albemarle (ALB)?

No. The Schedule includes a certification that the securities are held in the ordinary course of business and not to change or influence control.

Are convertible securities included in the reported share total?

Yes. The filing states 4,721,204 Convertible Preferred Stocks are included and represent 2,157,590 common shares.

When was the Schedule 13G signed?

The signature block shows the filing was signed by Jae Won Chung on 08/05/2025.